tirzepatide lilly FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Eli Lilly sues companies selling

Because the real goal is not simply becoming smaller

You should not take the Wegovy 7.2mg dose if you have a history of severe gastrointestinal issues on the lower doses, certain pre-existing medical conditions, or if you have not followed the dosing regimen from 0.25mg upwards

doi: 10.1038/oby.2009.510CrossRefGoogle ScholarPubMed Moaddel, R., Shardell, M., Khadeer, M., Lovett, J., Kadriu, B., Ravichandran, S., Zarate, C

report them promptly to PlexusDx and your physician

doi: 10.2337/dc13-2042 Summary Keywords athletes, carbohydrate timing, continuous glucose monitoring (CGM), glycemic control, nutrition, performance optimization, type 1 diabetes, type 2 diabetes Citation Xu L and Zhang W (2026) Nutritional considerations for athletes with diabetes: optimizing performance and glycemic control

Although the efficacy of this surgically implanted material was demonstrated, it induced cataract in virtually all phakic patients and severe glaucoma needing surgery in 28% of eyes (104, 105)